Antitumor activity of zoledronic acid in primary breast cancer cells determined by the ATP tumor chemosensitivity assay

BACKGROUND: The NeoAzure study has demonstrated that the use of the bisphosphonate zoledronic acid (Zol) in the neoadjuvant setting increases the rate of complete response in primary breast cancer and therefore indicates direct antitumor activity. The purpose of this study was to compare the antitum...

Descripción completa

Detalles Bibliográficos
Autores principales: Fehm, Tanja, Zwirner, Manfred, Wallwiener, Diethelm, Seeger, Harald, Neubauer, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3416722/
https://www.ncbi.nlm.nih.gov/pubmed/22824103
http://dx.doi.org/10.1186/1471-2407-12-308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3416722/
https://www.ncbi.nlm.nih.gov/pubmed/22824103
http://dx.doi.org/10.1186/1471-2407-12-308

Ejemplares similares